Associations	associations	O	O
between	between	O	O
use	use	O	O
of	of	O	O
benzodiazepines	benzodiazepines	S_chemical	O
or	or	O	O
related	related	O	O
drugs	drugs	O	O
and	and	O	O
health	health	O	O
,	,	O	O
physical	physical	O	O
abilities	abilities	O	O
and	and	O	O
cognitive	cognitive	O	O
function	function	O	O
:	:	O	O
a	a	O	O
non-randomised	non-randomised	O	O
clinical	clinical	O	O
study	study	O	O
in	in	O	O
the	the	O	O
elderly	elderly	O	O
.	.	O	O

OBJECTIVE	objective	O	O
:	:	O	O
To	to	O	O
describe	describe	O	O
associations	associations	O	O
between	between	O	O
the	the	O	O
use	use	O	O
of	of	O	O
benzodiazepines	benzodiazepines	S_chemical	O
or	or	O	O
related	related	O	O
drugs	drugs	O	O
(	(	O	O
BZDs/RDs	bzds/rds	O	O
)	)	O	O
and	and	O	O
health	health	O	O
,	,	O	O
functional	functional	O	O
abilities	abilities	O	O
and	and	O	O
cognitive	cognitive	O	O
function	function	O	O
in	in	O	O
the	the	O	O
elderly	elderly	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
A	a	O	O
non-randomised	non-randomised	O	O
clinical	clinical	O	O
study	study	O	O
of	of	O	O
patients	patients	O	O
aged	aged	O	O
>	>	O	O
or	or	O	O
=	=	O	O
65	65	O	O
years	years	O	O
admitted	admitted	O	O
to	to	O	O
acute	acute	O	O
hospital	hospital	O	O
wards	wards	O	O
during	during	O	O
1	1	O	O
month	month	O	O
.	.	O	O

164	164	O	O
patients	patients	O	O
(	(	O	O
mean	mean	O	O
age	age	O	O
+	+	O	O
/-	/-	O	O
standard	standard	O	O
deviation	deviation	O	O
[	[	O	O
SD	sd	O	O
]	]	O	O
81.6	81.6	O	O
+	+	O	O
/-	/-	O	O
6.8	6.8	O	O
years	years	O	O
)	)	O	O
were	were	O	O
admitted	admitted	O	O
.	.	O	O

Of	of	O	O
these	these	O	O
,	,	O	O
nearly	nearly	O	O
half	half	O	O
(	(	O	O
n	n	O	O
=	=	O	O
78	78	O	O
)	)	O	O

had	had	O	O
used	used	O	O
BZDs/RDs	bzds/rds	O	O
before	before	O	O
admission	admission	O	O
,	,	O	O
and	and	O	O
the	the	O	O
remainder	remainder	O	O
(	(	O	O
n	n	O	O
=	=	O	O
86	86	O	O
)	)	O	O
were	were	O	O
non-users	non-users	O	O
.	.	O	O

Cognitive	cognitive	O	O
ability	ability	O	O
was	was	O	O
assessed	assessed	O	O
by	by	O	O
the	the	O	O
Mini-Mental	mini-mental	O	O
State	state	O	O
Examination	examination	O	O
(	(	O	O
MMSE	mmse	O	O
)	)	O	O
.	.	O	O

Patients	patients	O	O
scoring	scoring	O	O
>	>	O	O
or	or	O	O
=	=	O	O
20	20	O	O
MMSE	mmse	O	O
sum	sum	O	O
points	points	O	O
were	were	O	O
interviewed	interviewed	O	O
(	(	O	O
n	n	O	O
=	=	O	O
79	79	O	O
)	)	O	O
and	and	O	O
questioned	questioned	O	O
regarding	regarding	O	O
symptoms	symptoms	O	O
and	and	O	O
functional	functional	O	O
abilities	abilities	O	O
during	during	O	O
the	the	O	O
week	week	O	O
prior	prior	O	O
to	to	O	O
admission	admission	O	O
.	.	O	O

Data	data	O	O
on	on	O	O
use	use	O	O
of	of	O	O
BZDs/RDs	bzds/rds	O	O
before	before	O	O
admission	admission	O	O
,	,	O	O
current	current	O	O
medications	medications	O	O
and	and	O	O
discharge	discharge	O	O
diagnoses	diagnoses	O	O
were	were	O	O
collected	collected	O	O
from	from	O	O
medical	medical	O	O
records	records	O	O
.	.	O	O

Health	health	O	O
,	,	O	O
physical	physical	O	O
abilities	abilities	O	O
and	and	O	O
cognitive	cognitive	O	O
function	function	O	O
were	were	O	O
compared	compared	O	O
between	between	O	O
BZD/RD	bzd/rd	O	O
users	users	O	O
and	and	O	O
non-users	non-users	O	O
,	,	O	O
and	and	O	O
adjustments	adjustments	O	O
were	were	O	O
made	made	O	O
for	for	O	O
confounding	confounding	O	O
variables	variables	O	O
.	.	O	O

The	the	O	O
residual	residual	O	O
serum	serum	O	O
concentrations	concentrations	O	O
of	of	O	O
oxazepam	oxazepam	O	O
,	,	O	O
temazepam	temazepam	O	O
and	and	O	O
zopiclone	zopiclone	O	O
were	were	O	O
analysed	analysed	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
The	the	O	O
mean	mean	O	O
+	+	O	O
/-	/-	O	O
SD	sd	O	O
duration	duration	O	O
of	of	O	O
BZD/RD	bzd/rd	O	O
use	use	O	O
was	was	O	O
7	7	O	O
+	+	O	O
/-	/-	O	O
7	7	O	O
years	years	O	O
(	(	O	O
range	range	O	O
1	1	O	O
-	-	O	O
31	31	O	O
)	)	O	O
.	.	O	O

Two	two	O	O
or	or	O	O
three	three	O	O
BZDs/RDs	bzds/rds	O	O
were	were	O	O
concomitantly	concomitantly	O	O
taken	taken	O	O
by	by	O	O
26	26	O	O
%	%	O	O
of	of	O	O
users	users	O	O
(	(	O	O
n	n	O	O
=	=	O	O
20	20	O	O
)	)	O	O
.	.	O	O

Long-term	long-term	O	O
use	use	O	O
of	of	O	O
these	these	O	O
drugs	drugs	O	O
was	was	O	O
associated	associated	O	O
with	with	O	O
female	female	O	O
sex	sex	O	O
and	and	O	O
use	use	O	O
of	of	O	O
a	a	O	O
higher	higher	O	O
number	number	O	O
of	of	O	O
drugs	drugs	O	O
with	with	O	O
effects	effects	O	O
on	on	O	O
the	the	O	O
CNS	cns	O	O
,	,	O	O
which	which	O	O
tended	tended	O	O
to	to	O	O
be	be	O	O
related	related	O	O
to	to	O	O
diagnosed	diagnosed	O	O
dementia	dementia	O	S_disease
.	.	O	O

After	after	O	O
adjustment	adjustment	O	O
for	for	O	O
these	these	O	O
variables	variables	O	O
as	as	O	O
confounders	confounders	O	O
,	,	O	O
use	use	O	O
of	of	O	O
BZDs/RDs	bzds/rds	O	O
was	was	O	O
not	not	O	O
associated	associated	O	O
with	with	O	O
cognitive	cognitive	O	O
function	function	O	O
as	as	O	O
measured	measured	O	O
by	by	O	O
the	the	O	O
MMSE	mmse	O	O
.	.	O	O

However	however	O	O
,	,	O	O
use	use	O	O
of	of	O	O
BZDs/RDs	bzds/rds	O	O
was	was	O	O
associated	associated	O	O
with	with	O	O
dizziness	dizziness	O	S_disease
,	,	O	O
inability	inability	O	O
to	to	O	O
sleep	sleep	O	O
after	after	O	O
awaking	awaking	O	O
at	at	O	O
night	night	O	O
and	and	O	O
tiredness	tiredness	O	O
in	in	O	O
the	the	O	O
mornings	mornings	O	O
during	during	O	O
the	the	O	O
week	week	O	O
prior	prior	O	O
to	to	O	O
admission	admission	O	O
and	and	O	O
with	with	O	O
stronger	stronger	O	O
depressive	depressive	O	S_disease
symptoms	symptoms	O	O
measured	measured	O	O
at	at	O	O
the	the	O	O
beginning	beginning	O	O
of	of	O	O
the	the	O	O
hospital	hospital	O	O
stay	stay	O	O
.	.	O	O

Use	use	O	O
of	of	O	O
BZDs/RDs	bzds/rds	O	O
tended	tended	O	O
to	to	O	O
be	be	O	O
associated	associated	O	O
with	with	O	O
a	a	O	O
reduced	reduced	O	O
ability	ability	O	O
to	to	O	O
walk	walk	O	O
and	and	O	O
shorter	shorter	O	O
night-time	night-time	O	O
sleep	sleep	O	O
during	during	O	O
the	the	O	O
week	week	O	O
prior	prior	O	O
to	to	O	O
admission	admission	O	O
.	.	O	O

A	a	O	O
higher	higher	O	O
residual	residual	O	O
serum	serum	O	O
concentration	concentration	O	O
of	of	O	O
temazepam	temazepam	O	O
correlated	correlated	O	O
with	with	O	O
a	a	O	O
lower	lower	O	O
MMSE	mmse	O	O
sum	sum	O	O
score	score	O	O
after	after	O	O
adjustment	adjustment	O	O
for	for	O	O
confounding	confounding	O	O
variables	variables	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Long-term	long-term	O	O
use	use	O	O
and	and	O	O
concomitant	concomitant	O	O
use	use	O	O
of	of	O	O
more	more	O	O
than	than	O	O
one	one	O	O
BZD/RD	bzd/rd	O	O
were	were	O	O
common	common	O	O
in	in	O	O
elderly	elderly	O	O
patients	patients	O	O
hospitalised	hospitalised	O	O
because	because	O	O
of	of	O	O
acute	acute	O	O
illnesses	illnesses	O	O
.	.	O	O

Long-term	long-term	O	O
use	use	O	O
was	was	O	O
associated	associated	O	O
with	with	O	O
daytime	daytime	O	O
and	and	O	O
night-time	night-time	O	O
symptoms	symptoms	O	O
indicative	indicative	O	O
of	of	O	O
poorer	poorer	O	O
health	health	O	O
and	and	O	O
potentially	potentially	O	O
caused	caused	O	O
by	by	O	O
the	the	O	O
adverse	adverse	O	O
effects	effects	O	O
of	of	O	O
these	these	O	O
drugs	drugs	O	O
.	.	O	O

